nominally significantp = 0.037
A nominally significant association with bleeding risk persisted only for rosuvastatin (OR = 2.189; 95% CI: 1.039–4.612; p = 0.037), but this finding should be interpreted with caution and regarded as exploratory. 3.4.
A nominally significant association with bleeding risk persisted only for rosuvastatin (OR = 2.189; 95% CI: 1.039–4.612; p = 0.037), but this finding should be interpreted with caution and regarded as exploratory. 3.4.
It is noteworthy that women with bleeding events tended to have lower height and body weight compared with women without complications, although these differences did not reach statistical significance.